American Journal of OphthalmologyVolume 146, Issue 6, December 2008, Pages 876-882This paper concludes:
"(Lumigan) is an effective IOP-lowering agent in patients with uveitic glaucoma in whom the uveitis is controlled on immunomodulatory therapy, and it does not increase the rate of flares of uveitis in these patients."
No comments:
Post a Comment
Leave a Comment or Question: